PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
7 hedge funds and large institutions have $22.9K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
8% more capital invested
Capital invested by funds: $21.2K → $22.9K (+$1.66K)
Top Buyers
Top Sellers
PVCT Hedge Fund Activity: Q1 2025 in Review
7 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q1 2025, worth a combined $22.9K — up 7.8% from $21.2K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PVCT positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
- 7 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q1 2025, up from 6 in Q4 2024.
- Funds reported $22.9K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q1 2025, up 7.8% quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q1 2025 and 0 closed out, a net change of +1 holder.
Based on aggregated 13F filings for Q1 2025.